Health & Medicine
One Platform, Three Goals: How mRNA Technology Is Being Retooled for Cancer and Autoimmune Disease
The mRNA technology behind COVID-19 vaccines is a flexible platform that can be retooled to instruct cells to produce specific proteins. This adaptability allows it to train the immune system to attack pathogens or cancer cells, or to induce tolerance in autoimmune diseases.
Marcus Cole·November 10, 2026
